Giancarlo Pruneri, MD, University of Milan, Milan, Italy, talks on the integration of personalized medicine with traditional histopathology. Despite the significant advances in the new technology for the personalization of medicine, Prof. Pruneri believes this should not replace traditional histopathology, but be placed within the workflow of cancer diagnosis and care. This interview took place at the European Society for Medical Oncology (ESMO) 2022 Congress in Paris, France.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.